Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Developing a surgical infection treatment to reduce amputations, healing times and hospital stays for diabetic foot patients

Descrizione del progetto

Un dispositivo innovativo per le infezioni del piede diabetico

Le infezioni dei tessuti profondi e delle ossa colpiscono ogni anno milioni di europei. I pazienti immunosoppressi sono particolarmente vulnerabili, poiché il 20 % delle infezioni del piede diabetico porta ad amputazioni. Il trattamento richiede più interventi chirurgici, lunghe degenze e assunzione di antibiotici a lungo termine. Le modalità terapeutiche attuali trattano solo la superficie della ferita o utilizzano forze meccaniche per trattarla al di sotto della stessa, ma sono spesso inefficaci. Il progetto XTremedy Medical, finanziato dall’UE, ha sviluppato un sistema di ablazione a campo pulsato, ossia un dispositivo chirurgico che eroga segnali elettrici attraverso la ferita. Il dispositivo tratta la superficie e la parte sottostante per annientare eventuali infezioni residue. La tecnologia non è termica e preserva l’integrità della ferita durante il trattamento, riducendo la necessità di un intervento chirurgico, il tempo di guarigione e la degenza in ospedale.

Obiettivo

XTremedy Medical is a surgical ablation company founded in 2018 to commercialize technology treating deep wound infections, including Diabetic Foot Infections (DFI). Our pulsed field ablation (PFA) system is the first to deliver electrical currents non-invasively to achieve superior clinical outcomes including faster cure of infections, reduced surgeries and shorter hospital stays.
The Problem:
Deep tissue and bone infections are life threatening infections that affect a millions of Europeans every year. Immunosuppressed patients are particularly vulnerable, with Diabetic Foot Ulcer Infections a leading cause of amputations in Europe. These patients are incredibly difficult to treat, requiring multiple surgeries, lengthy hospital stays and long-term antibiotics. In 20% of patients, an amputation is required to control the infection. Surgical intervention to remove infected tissue is the cornerstone of treatment but surgeons must balance removing infected material whilst preserving healthy tissue required for healing.
Treatment Landscape:
Current treatment modalities either only treat the surface of the wound or use mechanical forces to treat below the surface. Surface treatments fail as they leave infection below the wound bed untreated. Mechanical devices can cause more severe infections by damaging the integrity of the wound bed and propelling the infection deeper. As a result, these treatments are often ineffective, with 50% of patients requiring additional surgeries.
XTremedy Solution:
XTremedy Medical have developed a surgical device that delivers electrical signals through the wound. This device treats both the surface and below to zap any residual infection. The technology is non-thermal and preserves the integrity of the wound during treatment, helping reduce the time required for healing. Patients benefit from reduced surgeries, shortened hospital stays and antibiotic durations following surgery.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-CSA - HORIZON Coordination and Support Actions

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) HORIZON-EIE-2021-SCALEUP-01

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

XTREMEDY MEDICAL LIMITED
Contributo netto dell'UE
€ 75 000,00
Indirizzo
TRANSLATIONAL MEDICAL DEVICE LAB, 2ND FLOOR LAMBE TRANSLATIONAL RESEARCH FACILITY, UNIVERSITY COLLEGE HOSPITAL GALWAY, CO. GALWAY
H91ERW1 GALWAY
Irlanda
PMI
Sì
Regione
Ireland Northern and Western West
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Collegamenti
Costo totale
Nessun dato